Sangamo Biosciences reported $-45261000 in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Avrobio Inc AVRO:US -29418000 1.46M
Bayer BAYN:GR 2.02B 1.49B
Bluebird Bio BLUE:US $ -135.67M 81.29M
IONIS PHARMACEUT IONS:US $ 221M 306.85M
Novartis NOVN:VX 2.56B 671M
Regulus Therapeutics RGLS:US $ -6.57M 0.39M
Sangamo Biosciences SGMO:US $ -45.26M 5.36M
Ziopharm Oncology ZIOP:US $ -9085000 1.97M